Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

RESTORE

Financiado

RESTORE Health by Advanced Therapies Advanced Therapy Medicinal Products and Bi...

RESTORE Health by Advanced Therapies Advanced Therapy Medicinal Products and Biologized Medical Devices ALL for Advanced Therapies with Passion For Patients Recently, a new class of living drugs has been developed – Advanced Therapies which aim to transform the current focus of treatment of disease into one that concentrates on restoration of health with promising results in a broad f... ver más

31/07/2020

CHARITE UNIVERSIT...

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 12 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-07-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

FETFLAG-01-2018: Preparatory Actions for new FET Flagships

I+D

Cerrada hace 6 años

0% 100%

12 Participantes

CHARITE UNIVERSITAETSMEDIZI...

105.00K€ | Lider

SOTEC ENERGIAS RENOVABLES

390.05K€ | Participante

PLURI BIOTECH LTD

15.00K€ | Participante

INNOVATION ACTA SRL

587.50K€ | Participante

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 17 meses Fecha Inicio: 2019-02-08
Fecha Fin: 2020-07-31

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto Recently, a new class of living drugs has been developed – Advanced Therapies which aim to transform the current focus of treatment of disease into one that concentrates on restoration of health with promising results in a broad field of Regenerative Medicine, including targeted immune reconstitution for cancer treatment. Advanced Therapies are game changing in Health Care and have a rapidly expanding market size of approximately 12 and 50 bn € expected by 2020 and 2030, respectively. There is great value in European science and technology on Advanced Therapies but Europe has been losing ground because of scattered and underpowered efforts. If Europe wants a leading role in this emerging field in the future, a mission-driven approach is required to make the transforming promise of Advanced Therapies a reality. The development of new Advanced Therapy products and their implementation in clinical practice will enhance the value-based outcome of patients. Measurable by having dozens of premier-league Advanced Therapy Products discovered & made in Europa by 2030 and beyond. Bringing affordable, standard-of-care for currently incurable diseases which are accessible for every European citizen who need it to RESTORE Health. We propose a mission-driven programme led by the candidate LSRI RESTORE, aiming to build a coordinated, financially strong European partnership between different areas of interest and cross-sectors involving academia, industry, regulatory authorities, health care, patient organisations, and public society. In order to guarantee a smart start of the LSRI from 2021 onwards, the preparation phase aims to involve the growing RESTORE community even more closely in working groups on identified tasks and to jointly complete the RESTORE agenda for Research & Innovation Actions as well as Coordination & Support Actions. The deliverables of RESTORE will allow Europe to gain a world leading health position within this emerging field.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores